<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02892851</url>
  </required_header>
  <id_info>
    <org_study_id>P111014</org_study_id>
    <nct_id>NCT02892851</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation of the Sub-Thalamic Nucleus to Treat Severe and Treatment-resistant Cocaine Addiction.</brief_title>
  <acronym>STUC</acronym>
  <official_title>A Pilot Study of Deep Brain Stimulation of the Sub-thalamic Nucleus to Treat Treatment-resistant Cocaine Addiction With Severe Somatic or Psychiatric Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cocaine addiction is a chronic condition with severe cardiac, neurologic, psychiatric and&#xD;
      social complications. Cocaine is the second most consumed illicit drug in France. Its&#xD;
      prevalence has been multiplied by 3 between 2000 and 2008, and is still on the rise. Craving,&#xD;
      the compulsive need to consume, is a key feature of cocaine addiction. It is also predictive&#xD;
      of treatment efficacy. However, there is no validated treatment for severe cocaine dependence&#xD;
      yet. Response to current psychological and medical treatment is poor, with 73% relapse after&#xD;
      3 months. Patients with severe cocaine addiction are thus in a therapeutic deadlock.&#xD;
&#xD;
      To address these unmet medical needs, the investigators designed a pilot study (n=2) to&#xD;
      evaluate the safety and the efficacy of the deep brain stimulation of the subthalamic nuclei&#xD;
      (STN-DBS) in severe cocaine addiction with at least one cardiac, neurologic or psychiatric&#xD;
      complication. Indeed, compulsivity is a critical component of craving, and severe&#xD;
      treatment-resistant obsessive compulsive disorder (OCD) are already successfully treated&#xD;
      using STN-DBS. Moreover, animal studies recently demonstrated a therapeutic effect of STN-DBS&#xD;
      in rats addicted to cocaine. Together, these two lines of research suggest a therapeutic&#xD;
      effect of STN-DBS in cocaine addiction mediated by an anti-obsessive mechanism on craving.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of the Obsessive Compulsive Cocaine Scale (OCCS) craving score</measure>
    <time_frame>at month 6</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychiatric assessment by standardized interview</measure>
    <time_frame>Month -2, Month 2, Month 3, Month 3+15 days, Month 4+15days, Month 6, Month 7, Month 8, Month 9, Month10 (+1,5)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cocaine Craving Questionnaire (CCQ) craving score</measure>
    <time_frame>Month -2, Month 2 (1day), Month 2 (2nd day), Month 2 (3rd day), Month 3, Month 3+15 days, Month 4+15days, Month 6, Month 7, Month 8, Month 9, Month 10 (+1,5)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self assessed addiction criteria</measure>
    <time_frame>Month -2, Month 2, Month 3, Month 3+15 days, Month 4+15days, Month 6, Month 7, Month 8, Month 9, Month10 (+1,5)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine screening assay for cocaine use / Urine Drug Screening</measure>
    <time_frame>Month -2, Month 2, Month 3, Month 3+15 days, Month 4+15days, Month 6, Month 7, Month 8, Month 9, Month10 (+1,5)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Capillary screening assay for cocaine use</measure>
    <time_frame>Month -2, Month 4,5 and Month 10 (+1,5)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of Global Assessment of Functioning scale (GAF)</measure>
    <time_frame>Month -2, Month 2, Month 3, Month 3+15 days, Month 4+15days, Month 6, Month 7, Month 8, Month 9, Month10 (+1,5)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">2</enrollment>
  <condition>Cocaine Addiction</condition>
  <arm_group>
    <arm_group_label>Deep brain stimulation (DBS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Deep brain stimulation of the subthalamic nuclei (STN-DBS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep brain stimulation of the subthalamic nuclei (STN-DBS)</intervention_name>
    <description>3 phases :&#xD;
Parameter setting&#xD;
Cross-over double-bind (ON/OFF)&#xD;
Open Phase (ON)</description>
    <arm_group_label>Deep brain stimulation (DBS)</arm_group_label>
    <other_name>Activa PC Medtronic (7428) stimulator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  severe and resistant Cocaine Dependence for 5 years defined as:&#xD;
&#xD;
               -  cocaine dependence (DSM IV),&#xD;
&#xD;
               -  preferential use of cocaine in base form (crack or free-base) through smoke,&#xD;
&#xD;
               -  non response to at least two well-conducted treatment with at least a stay in&#xD;
                  aftercare,&#xD;
&#xD;
               -  severe physical complications (defined as a history of myocardial infarction,&#xD;
                  stroke).&#xD;
&#xD;
          -  psychotic syndromes induced recurrent, severe lung disease &quot;crack-lungs&quot;) occurred due&#xD;
             to crack consumption and whose association with the crack use is known to the patient&#xD;
&#xD;
          -  age between 30 and 55 years&#xD;
&#xD;
          -  patient affiliated to a social security scheme&#xD;
&#xD;
          -  patient signed an informed consent after receiving written information on the proposed&#xD;
             procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  a current opioid dependence will not be a criterion of non inclusion if the patient is&#xD;
             undergoing substitution treatment (methadone or buprenorphine) and not injection of&#xD;
             opiates for at least six months.&#xD;
&#xD;
          -  patient trust&#xD;
&#xD;
          -  pregnant, nursing or of childbearing potential without effective contraception&#xD;
&#xD;
          -  current use of the intravenous route for the administration of the drugs is the risk&#xD;
             of infection&#xD;
&#xD;
          -  VIH infection or VHC unstabilized,&#xD;
&#xD;
          -  cardiovascular and / or brain state is not compatible with the surgery,&#xD;
&#xD;
          -  other disorder on Axis I not linked to cocaine use except:&#xD;
&#xD;
               -  current or past dependence to nicotine,&#xD;
&#xD;
               -  abuse or dependence on other psychoactive substances over a lifetime in remission&#xD;
                  for more than 6 months,&#xD;
&#xD;
               -  current opioid dependence: if the patient is undergoing substitution treatment&#xD;
                  (methadone or buprenorphine) and not injection of opiates for at least 6 months,&#xD;
&#xD;
               -  when other psychiatric disorders induced by substances.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Luc MALLET</last_name>
    <phone>(0)1 49 81 30 52</phone>
    <phone_ext>+33</phone_ext>
    <email>luc.mallet@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Florence VORSPAN</last_name>
    <phone>(0) 1 40 05 44 17</phone>
    <phone_ext>+33</phone_ext>
    <email>florence.vorspan@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Henri Mondor Hospital</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe DOMENECH</last_name>
      <phone>(0) 1 49 81 22 03</phone>
      <phone_ext>+33</phone_ext>
      <email>philippe.domenech@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>August 18, 2016</study_first_submitted>
  <study_first_submitted_qc>September 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2016</study_first_posted>
  <last_update_submitted>September 1, 2016</last_update_submitted>
  <last_update_submitted_qc>September 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STN-DBS</keyword>
  <keyword>Craving</keyword>
  <keyword>Cocaine addiction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine-Related Disorders</mesh_term>
    <mesh_term>Behavior, Addictive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

